Cabozantinib in Advanced Salivary Gland Cancer Patients

Condition:   Salivary Gland Cancer
Intervention:   Drug: Cabozantinib
Sponsors:   Radboud University;   Ipsen
Recruiting

https://ift.tt/2JAhTC7